Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 10(3): e0119910, 2015.
Article in English | MEDLINE | ID: mdl-25768013

ABSTRACT

Cortical and hippocampal hypersynchrony of neuronal networks seems to be an early event in Alzheimer's disease pathogenesis. Many mouse models of the disease also present neuronal network hypersynchrony, as evidenced by higher susceptibility to pharmacologically-induced seizures, electroencephalographic seizures accompanied by spontaneous interictal spikes and expression of markers of chronic seizures such as neuropeptide Y ectopic expression in mossy fibers. This network hypersynchrony is thought to contribute to memory deficits, but whether it precedes the onset of memory deficits or not in mouse models remains unknown. The earliest memory impairments in the Tg2576 mouse model of Alzheimer's disease have been observed at 3 months of age. We thus assessed network hypersynchrony in Tg2576 and non-transgenic male mice at 1.5, 3 and 6 months of age. As soon as 1.5 months of age, Tg2576 mice presented higher seizure susceptibility to systemic injection of a GABAA receptor antagonist. They also displayed spontaneous interictal spikes on EEG recordings. Some Tg2576 mice presented hippocampal ectopic expression of neuropeptide Y which incidence seems to increase with age among the Tg2576 population. Our data reveal that network hypersynchrony appears very early in Tg2576 mice, before any demonstrated memory impairments.


Subject(s)
Alzheimer Disease/physiopathology , Biomarkers/metabolism , Electroencephalography Phase Synchronization/physiology , Nerve Net/physiopathology , Seizures/physiopathology , Age Factors , Alzheimer Disease/complications , Analysis of Variance , Animals , Electroencephalography , Electroencephalography Phase Synchronization/drug effects , GABA-A Receptor Antagonists/pharmacology , Immunohistochemistry , Male , Mice , Mice, Transgenic , Neuropeptide Y/metabolism , Seizures/complications , Seizures/metabolism
2.
Learn Mem ; 21(6): 311-5, 2014 May 15.
Article in English | MEDLINE | ID: mdl-25171422

ABSTRACT

Protein synthesis is involved in the consolidation of short-term memory into long-term memory. Previous electrophysiological data concerning LTP in CA3 suggest that protein synthesis in that region might also be necessary for short-term memory. We tested this hypothesis by locally injecting the protein synthesis inhibitor anisomycin in hippocampal area CA1 or CA3 immediately after contextual fear conditioning. As previously shown, injections in CA1 impaired long-term memory but spared short-term memory. Conversely, injections in CA3 impaired both long-term and short-term memories. We conclude that early steps of experience-induced plasticity occurring in CA3 and underlying short-term memory require protein synthesis.


Subject(s)
Anisomycin/pharmacology , CA3 Region, Hippocampal/metabolism , Fear/physiology , Memory, Long-Term/physiology , Memory, Short-Term/physiology , Protein Synthesis Inhibitors/pharmacology , Animals , CA3 Region, Hippocampal/drug effects , Conditioning, Classical , Fear/drug effects , Male , Memory, Long-Term/drug effects , Memory, Short-Term/drug effects , Mice , Mice, Inbred C57BL , Neuronal Plasticity/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...